Atopic dermatitis therapeutics - Verge Genomics
Latest Information Update: 07 Feb 2024
At a glance
- Originator Verge Genomics
- Class Anti-inflammatories; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Atopic dermatitis
Most Recent Events
- 22 Dec 2023 Early research in Atopic dermatitis in USA (unspecified route), prior to December 2023 (Verge Genomics pipeline, December 2023)